Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon

Clinical Microbiology and Infection

Volumn 14, Issue 9, 2008, Pages 887-888

  Matar, G M ^a   Cuzon, G ^b   Araj, G F ^a   Naas, T ^b   Corkill, J ^c   Kattar, M M ^a   Nordmann, P ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; BACTERIAL ENZYME; BETA LACTAMASE; BETA LACTAMASE OXA 48; CARBAPENEM DERIVATIVE; CEFALOTIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; COTRIMOXAZOLE; ERTAPENEM; IMIPENEM; OXACILLINASE; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TICARCILLIN; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; CASE REPORT; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE SEQUENCE; HUMAN; KLEBSIELLA PNEUMONIAE; LEBANON; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; URINARY TRACT INFECTION;

KLEBSIELLA PNEUMONIAE;

EID: 50149087907     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02059.x     Document Type: Letter

References (12)

1. Deshpande LM, Jones RN, Fritsche TR et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: Report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist 2006; 12: 223-230.
2. Poirel L, Pitout JD, Nordmann P. Carbapenemases: Molecular diversity and clinical consequences. Future Microbiol 2007; 2: 501-512.
3. Kanj SS, Corkill JE, Kanafani ZE et al. Molecular characterisation of extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolates at a tertiary care centre in Lebanon. Clin Microbiol Infect 2008; 14: 501-504.
4. Cuzon G, Naas T, Demachy MC et al. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2007; 52: 796-797.
5. Navon-Venezia S, Chmelnitsky I, Leavitt A et al. Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother 2006; 50: 3098-3101.
6. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007; 51: 3026-3029.
7. Poirel L, Héritier C, Tolun V et al. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004; 48: 15-22.
8. Queenan AM, Bush K. Carbapenemases: The versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-458.
9. Gülmez D, Woodford N, Palepou MF et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008; 31: 523-526.
10. Aktaş Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumoniae in Istanbul, Turkey. Chemotherapy 2008; 54: 101-106.
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th Informational Supplement M100-S15. Wayne, PA: CLSI, 2005.
12. Naas T, Zerbib M, Girlich D, Nordmann P. Integration of a transposon Tn1-encoded inhibitor-resistant beta-lactamase gene, bla(TEM-67) from Proteus mirabilis, into the Escherichia coli chromosome. Antimicrob Agents Chemother 2003; 47: 19-26.